Skip to content
  • Add anything here or just remove it...
ImpentriImpentri
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact

Flatsome Elements

Flatsome is more than a theme. It's a framework for creating amazing Websites. Here is a collection of our highly customisable elements.

Sections

Rows / Columns

Sliders

Banners

Typography

Buttons

Titles / Dividers

Blog Posts

Images

Video

Galleries

Video Button

Banner Grids

Icon Box

Image Box

Lightbox

Scroll To

Pages

Contact

Left Sidebar

Maintenance

Our Stores

Size Chart

FAQ

Portfolio

Map

Message box

Product Categories

Products

Share / follow icons

Tabs

Team Member

Testimonials

Countdown

Flip Book

Hotspot

Forms

Price table

Search box

Instagram feed

Accordion

Logo

  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005142.

This Joint Undertaking receives support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.

IMPENTRI IMI2Follow

IMPENTRI IMI2
Imi2Impentri
6 Oct

Congratulations to the team on their paper "Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: lessons from the CounterCovid imatinib study, accepted into #PSPJournal.
See it here https://ascpt.onlinelibrary.wiley.com/doi/10.1002/psp4.12718
@ASCPTjournals

Reply on Twitter 1445711357274255362Retweet on Twitter 14457113572742553621Like on Twitter 14457113572742553621Twitter 1445711357274255362
biljana_parapid
27 Aug

#ESCCongress 2nd talk by Dr Duijvelaar 🇳🇱
Promising results for #Imatinib & announcement for 3 new @WHO solidarity trials ‼️

#Covid19 #vaccination strongly advised by entire panel as risk for post💉 myo-/peri-carditis much lower than 4 acute 🦠

@avolgman @Hragy @NitiCardio

4
Reply on Twitter 1431148653570404354Retweet on Twitter 14311486535704043546Like on Twitter 14311486535704043548Twitter 1431148653570404354
Imi2Impentri
10 May 2021

International COVID-19 trial to restart with focus on immune responses https://www.nature.com/articles/d41586-021-01090-z

Reply on Twitter 1391712907021406210Retweet on Twitter 1391712907021406210Like on Twitter 13917129070214062102Twitter 1391712907021406210
Load More...
Copyright 2022 © Exvastat Ltd
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact
  • WooCommerce not Found